A cannabis-based medicine can now be prescribed to sufferers of a rare genetic condition which causes seizures as part of a raft of drugs approved for use on the Scottish health service. Epidyolex, or cannabidiol, was approved by the Scottish Medicines Consortium( SMC) on Monday for use on patients as young as two years old with seizures associated with tuberous sclerosis complex, a rare genetic condition which requires round the clock care and impacts on all aspects of life. Consortium chairman

Is there anyone in the U.S. who hasn’t experienced one or more of these indignities?... Most Americans have no rights or remedies.” Rosenfield is one of our most effective consumer advocates.... A former Nader’s Raider, he’s the founder of the advocacy group Consumer Watchdog and was the author of the California’s landmark Proposition 103 of 1988....